Noble launches YpsoMate training device platform for patient injection treatments

Noble, a medical device training solutions supplier, has announced a new injection training platform based on 1 mL and 2.25 mL YpsoMate devices to help improve patient onboarding and health outcomes.

Given that 49 percent of patients prescribed injection-based therapies do not receive training in a healthcare providers’ office and 90 percent of treatment information is forgotten in a week, it’s important for brands to take a holistic approach to ensuring patients are familiar and confident with using their device, understand their condition and treatment plan and remain adherent to therapy. Noble’s training and onboarding solutions accomplish just that by providing patients with an assortment of educational support tools and materials to make up for any treatment, learning and other gaps they may experience.

Noble’s convenient, forward-looking YpsoMate training platform – which centers on a resettable, pre-tooled core device with a variety of plunger speed options – benefits brands by delivering superior quality, faster speed to market (including utilization in clinical trials and commercial launch planning) and no capital tooling expense.

Meanwhile, users will benefit from having a comprehensive, engaging training and onboarding system that provides healthcare providers with an in-office resource for educating patients and offers patients an in-home solution for multi-use practice sessions and interactive firsthand training on demand.